Hogan Lovells advises Valneva on €40m capital increase
Hogan Lovells has advised Valneva — a fully integrated European biotech company created in 2013 through the merger of Vivalis and Intercell — on a fully underwritten €40m capital increase with preferential subscription rights.
The law firm previously advised Vivalis in relation to its merger with Intercell.
The team in charge of the deal was made up of Jean-Marc Franceschi, Paris corporate partner, assisted by Thomas Saint-Loubert-Bié, Virginie Aïdan (tax), and John Basnage (international aspects), London corporate partner, assisted by Jaime Huertas.
News from Hogan Lovells
News from The Lawyer
Briefings from Hogan Lovells
With increasing internet penetration throughout the country, the e-commerce industry, like other industries in China, is growing at a swift pace.
A tribunal decision that required a committed Christian to work on a Sunday on an occasional basis in accordance with her contract of employment did not discriminate against her.
Analysis from The Lawyer
The Lawyer’s latest Top 50 litigation firms list shows that business for dispute specialists is roaring along while new in-depth detail reveals the winning strategies
The Russian legal market faces a new era as the government opens the door to greater business transparency, but not everything is open to scrutiny